ClinicalTrials.gg

Drug class

Beta-Lactamase Inhibitors clinical trials

A class of medicines: the studies that test any of its 23 members, each study once. Members are as MeSH files each medicine’s actions, and as the NCI Thesaurus classes newer ones.

studies test it
294
open now
48
in phase 3
60
first study started
1997

Keep track of what changes. Save the beta-lactamase inhibitors studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

Medicines in this class

Studies that test each. A study of two counts under both, and once above.

Piperacillin, Tazobactam Drug Combination
48
Ceftolozane, tazobactam drug combination
19
Avibactam, ceftazidime drug combination
16
QPX7728
2
L 084
1
Vaborbactam
1
Ticarcillin-clavulanic acid
1

Studies by the year they started

291 studies that test it; most in 2019 (19); 2 more planned to start later

Studies that test beta-Lactamase Inhibitors, by start year
YearStudies
19971
19981
19991
20002
20011
20023
20035
20044
20054
20069
20072
20083
20098
201011
201110
201215
201318
201415
201512
201617
201715
201813
201919
202018
202110
202212
202315
202413
202517
202617

By phase

A phase 1/2 study counts in both.

Early Phase 1
2
Phase 1
78
Phase 2
41
Phase 3
60
Phase 4
90
No phase
35

What it is tested for

Each study’s main condition, where its own words name it.

Who runs them

Industry 116 · Other 178

Pfizer (19) · Merck Sharp & Dohme LLC (13) · Spero Therapeutics (11) · Wyeth is now a wholly owned subsidiary of Pfizer (9) · Wockhardt (6) · Qilu Pharmaceutical Co., Ltd. (6) · Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) (6) · Qpex Biopharma, Inc. (5)

Studies

Open first, then newest update. How each study uses a medicine is read from its arms, and is right about nine times in ten.

Testing one of them · 294

See all 294 studies that test one of the beta-lactamase inhibitors →